88 related articles for article (PubMed ID: 22242445)
1. [Research progress of selective mGluR1 antagonists].
Yang YL; Sun W; Peng C; Zhang XY; Yang XH
Yao Xue Xue Bao; 2011 Oct; 46(10):1167-72. PubMed ID: 22242445
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists.
Zheng GZ; Bhatia P; Daanen J; Kolasa T; Patel M; Latshaw S; El Kouhen OF; Chang R; Uchic ME; Miller L; Nakane M; Lehto SG; Honore MP; Moreland RB; Brioni JD; Stewart AO
J Med Chem; 2005 Nov; 48(23):7374-88. PubMed ID: 16279797
[TBL] [Abstract][Full Text] [Related]
3. Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models.
Kohara A; Nagakura Y; Kiso T; Toya T; Watabiki T; Tamura S; Shitaka Y; Itahana H; Okada M
Eur J Pharmacol; 2007 Sep; 571(1):8-16. PubMed ID: 17597604
[TBL] [Abstract][Full Text] [Related]
4. Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain.
Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Li C; Heimark L; Pramanik B; Grilli M; Bertorelli R; Lozza G; Reggiani A
Bioorg Med Chem Lett; 2009 Jun; 19(12):3199-203. PubMed ID: 19433355
[TBL] [Abstract][Full Text] [Related]
5. 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity.
Fisher MJ; Backer RT; Barth VN; Garbison KE; Gruber JM; Heinz BA; Iyengar S; Hollinshead SP; Kingston A; Kuklish SL; Li L; Nisenbaum ES; Peters SC; Phebus L; Simmons RM; van der Aar E
Bioorg Med Chem Lett; 2012 Apr; 22(7):2514-7. PubMed ID: 22386665
[TBL] [Abstract][Full Text] [Related]
6. Discovery of orally efficacious tetracyclic metabotropic glutamate receptor 1 (mGluR1) antagonists for the treatment of chronic pain.
Wu WL; Burnett DA; Domalski M; Greenlee WJ; Li C; Bertorelli R; Fredduzzi S; Lozza G; Veltri A; Reggiani A
J Med Chem; 2007 Nov; 50(23):5550-3. PubMed ID: 17929793
[TBL] [Abstract][Full Text] [Related]
7. Radioligand binding properties and pharmacological characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo[3,2-a]benzimidazole-2-carboxamide (YM-298198), a high-affinity, selective, and noncompetitive antagonist of metabotropic glutamate receptor type 1.
Kohara A; Toya T; Tamura S; Watabiki T; Nagakura Y; Shitaka Y; Hayashibe S; Kawabata S; Okada M
J Pharmacol Exp Ther; 2005 Oct; 315(1):163-9. PubMed ID: 15976016
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of aryl isoxazole derivatives as metabotropic glutamate receptor 1 antagonists: a potential treatment for neuropathic pain.
Cho GH; Kim T; Son WS; Seo SH; Min SJ; Cho YS; Keum G; Jeong KS; Koh HY; Lee J; Pae AN
Bioorg Med Chem Lett; 2015 Mar; 25(6):1324-8. PubMed ID: 25677662
[TBL] [Abstract][Full Text] [Related]
9. Blockade of mGluR1 receptor results in analgesia and disruption of motor and cognitive performances: effects of A-841720, a novel non-competitive mGluR1 receptor antagonist.
El-Kouhen O; Lehto SG; Pan JB; Chang R; Baker SJ; Zhong C; Hollingsworth PR; Mikusa JP; Cronin EA; Chu KL; McGaraughty SP; Uchic ME; Miller LN; Rodell NM; Patel M; Bhatia P; Mezler M; Kolasa T; Zheng GZ; Fox GB; Stewart AO; Decker MW; Moreland RB; Brioni JD; Honore P
Br J Pharmacol; 2006 Nov; 149(6):761-74. PubMed ID: 17016515
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain.
Brumfield S; Korakas P; Silverman LS; Tulshian D; Matasi JJ; Qiang L; Bennett CE; Burnett DA; Greenlee WJ; Knutson CE; Wu WL; Sasikumar TK; Domalski M; Bertorelli R; Grilli M; Lozza G; Reggiani A; Li C
Bioorg Med Chem Lett; 2012 Dec; 22(23):7223-6. PubMed ID: 23084894
[TBL] [Abstract][Full Text] [Related]
11. Discovery and biological evaluation of tetrahydrothieno[2,3-c]pyridine derivatives as selective metabotropic glutamate receptor 1 antagonists for the potential treatment of neuropathic pain.
Nam M; Kim T; Kwak J; Seo SH; Ko MK; Lim EJ; Min SJ; Cho YS; Keum G; Baek DJ; Lee J; Pae AN
Eur J Med Chem; 2015 Jun; 97():245-58. PubMed ID: 25984841
[TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1.
Nataraja Sekhar Y; Ravikumar M; Ravi Shashi Nayana M; Mallena SC; Kishore Kumar M
Eur J Med Chem; 2008 May; 43(5):1025-34. PubMed ID: 17822809
[TBL] [Abstract][Full Text] [Related]
13. Discovery and SAR of potent, orally available and brain-penetrable 5,6-dihydro-4H-3-thia-1-aza-benzo[e]azulen- and 4,5-dihydro-6-oxa-3-thia-1-aza-benzo[e]azulen derivatives as neuropeptide Y Y5 receptor antagonists.
Rueeger H; Gerspacher M; Buehlmayer P; Rigollier P; Yamaguchi Y; Schmidlin T; Whitebread S; Nuesslein-Hildesheim B; Nick H; Cricione L
Bioorg Med Chem Lett; 2004 May; 14(10):2451-7. PubMed ID: 15109631
[TBL] [Abstract][Full Text] [Related]
14. From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolines: a new class of orally bioavailable mGluR1 antagonists.
Di Fabio R; Micheli F; Alvaro G; Cavanni P; Donati D; Gagliardi T; Fontana G; Giovannini R; Maffeis M; Mingardi A; Tranquillini ME; Vitulli G
Bioorg Med Chem Lett; 2007 Apr; 17(8):2254-9. PubMed ID: 17276684
[TBL] [Abstract][Full Text] [Related]
15. Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonists.
Zheng GZ; Bhatia P; Kolasa T; Patel M; El Kouhen OF; Chang R; Uchic ME; Miller L; Baker S; Lehto SG; Honore P; Wetter JM; Marsh KC; Moreland RB; Brioni JD; Stewart AO
Bioorg Med Chem Lett; 2006 Sep; 16(18):4936-40. PubMed ID: 16809035
[TBL] [Abstract][Full Text] [Related]
16. Fused tricyclic mGluR1 antagonists for the treatment of neuropathic pain.
Bennett CE; Burnett DA; Greenlee WJ; Knutson CE; Korakas P; Li C; Tulshian D; Wu WL; Bertorelli R; Fredduzzi S; Grilli M; Lozza G; Reggiani A; Veltri A
Bioorg Med Chem Lett; 2012 Feb; 22(4):1575-8. PubMed ID: 22266036
[TBL] [Abstract][Full Text] [Related]
17. The identification of novel orally active mGluR5 antagonist GSK2210875.
Pilla M; Andreoli M; Tessari M; Delle-Fratte S; Roth A; Butler S; Brown F; Shah P; Bettini E; Cavallini P; Benedetti R; Minick D; Smith P; Tehan B; D'Alessandro P; Lorthioir O; Ball C; Garzya V; Goodacre C; Watson S
Bioorg Med Chem Lett; 2010 Dec; 20(24):7521-4. PubMed ID: 21051228
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and analgesic/anti-inflammatory evaluation of fused heterocyclic ring systems incorporating phenylsulfonyl moiety.
Shaaban MR; Saleh TS; Mayhoub AS; Mansour A; Farag AM
Bioorg Med Chem; 2008 Jun; 16(12):6344-52. PubMed ID: 18502132
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
[TBL] [Abstract][Full Text] [Related]
20. Virtual screening for selective allosteric mGluR1 antagonists and structure-activity relationship investigations for coumarine derivatives.
Noeske T; Jirgensons A; Starchenkovs I; Renner S; Jaunzeme I; Trifanova D; Hechenberger M; Bauer T; Kauss V; Parsons CG; Schneider G; Weil T
ChemMedChem; 2007 Dec; 2(12):1763-73. PubMed ID: 17868161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
